ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy ...

Around one in seven adults in the United States have chronic kidney disease (CKD), a condition in which the kidneys become damaged and can’t work as efficiently. This allows waste products to build up ...

Weaning patients with acute kidney injury (AKI) from dialysis while they are still hospitalized may save them from remaining on the treatment for the rest of their lives, according to a new study led ...

CAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today ...

Plans to Initiate Phase 2 Basket Study in Glomerular Kidney Diseases in 2Q24 CAMBRIDGE, Mass., April 15, 2024 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed clinical ...

Please provide your email address to receive an email when new articles are posted on . Incidence of end-stage kidney disease for those with newly diagnosed antibody-associated vasculitis was 22% at ...

Patients with chromophobe RCC are more likely to experience complete recovery of kidney function after radical nephrectomy, and this is associated with better survival. While uncommon, complete ...

A less intensive dialysis strategy is feasible for stable patients with acute kidney injury, but warrants further testing. A conservative vs conventional approach to hemodialysis may help ...